UPDATE: Congress on Friday, Dec. 20, passed a slimmed down version of the original continuing resolution with no physician Medicare pay fix. 

The BCBS decision pertains to gadopiclenol, a gadolinium-based product sold under the brand names Elucirem and Vueway. 

ACR noted that the state already is struggling to recruit and retain physicians, with the policy potentially exacerbating the problem. 

New findings indicate as many as 96% of men with positive PSA labs who show insignificant or slow-growing cancer on MRI can safely forego biopsy for three or more years. 

The new data mark a positive change amid years of healthcare staffing woes amplified by the COVID-19 pandemic. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.